ADC Outsourcing: Plan Smart Now Or Suffer Later

Antibody-drug conjugates (ADCs) bring together multiple scientific and operational disciplines, which makes early and ongoing outsourcing decisions especially consequential. This event examines how sponsors think through outsourcing strategies across discovery support, process development, bioconjugation, analytical work, drug substance, and fill-finish, focusing on what should remain internal and what should be outsourced to external partners. Our panel will discuss how to evaluate capabilities, sequence development activities, avoid fragmentation across vendors, and build an outsourcing plan that supports speed without creating unnecessary technical or program risk.